Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Akari Therapeutics Plc (AKTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
09/29/2023 6-K Quarterly results
08/18/2023 6-K Quarterly results
08/17/2023 F-6 POS Form F-6 POS - Post-effective amendments for immediately effective filing:
08/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Akari Therapeutics, Plc Announces ADS Ratio Change"
08/02/2023 6-K Quarterly results
07/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Akari Therapeutics Granted Nomacopan Orphan Drug Designation from the European Commission for Treatment in Hematopoietic Stem Cell Transplantation"
07/25/2023 6-K Quarterly results
07/19/2023 6-K Quarterly results
07/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Akari Therapeutics Provides Updates on Development of Nomacopan in Pediatric and Adult HSCT-TMA"
07/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Akari Therapeutics Provides Update on Development of Long-Acting PAS-Nomacopan for Treatment of Geographic Atrophy"
07/07/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Amended Articles of Association of Akari Therapeutics, Plc",
"Amended Articles of Association of Akari Therapeutics, Plc"
07/06/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Akari Therapeutics Receives Positive Opinion on Orphan Drug Designation from the European Medicines Agency for Nomacopan for Treatment in Hematopoietic Stem Cell Transplantation"
07/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K",
"Akari Therapeutics Appoints Industry Veteran Wa’ el Hashad to Board of Directors"
06/30/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
06/07/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/07/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/31/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/31/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/31/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/05/2023 6-K Quarterly results
05/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
05/01/2023 6-K Quarterly results
04/25/2023 6-K Quarterly results
04/14/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/31/2023 6-K Quarterly results
03/31/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/29/2023 6-K Quarterly results
03/28/2023 6-K Quarterly results
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/14/2023 SC 13G/A Patel Samir Rashmikant reports a 9.9% stake in Akari Therapeutics, PLC
02/13/2023 6-K Quarterly results
11/10/2022 6-K Quarterly results
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy